IL-1beta binding antibodies for use in treating cancer
Use of an IL-1β binding antibody or a functional fragment thereof, especially canakinumab or a functional fragment thereof, or gevokizumab or a functional fragment thereof, and biomarkers for the treatment and/or prevention of cancer with at least partial inflammatory basis.
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Ligueros-Saylan, Monica Lau, Yi Yang Libby, Peter Matchaba, Patrice Ridker, Paul Ottewell, Penelope Thuren, Tom Dugan, Margaret |
| description | Use of an IL-1β binding antibody or a functional fragment thereof, especially canakinumab or a functional fragment thereof, or gevokizumab or a functional fragment thereof, and biomarkers for the treatment and/or prevention of cancer with at least partial inflammatory basis. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2018287519BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2018287519BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2018287519BB23</originalsourceid><addsrcrecordid>eNrjZDDz9NE1TEotSVRIysxLycxLV0jMK8lMyk_JTC1WSMsvUigtTlXIzFMoKUpNLAFJJyfmJacW8TCwpiXmFKfyQmluBhU31xBnD93Ugvz41OKCxOTUvNSSeMdQIwNDCyMLc1NDSycnI2MilQEAQhYuLg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>IL-1beta binding antibodies for use in treating cancer</title><source>esp@cenet</source><creator>Ligueros-Saylan, Monica ; Lau, Yi Yang ; Libby, Peter ; Matchaba, Patrice ; Ridker, Paul ; Ottewell, Penelope ; Thuren, Tom ; Dugan, Margaret</creator><creatorcontrib>Ligueros-Saylan, Monica ; Lau, Yi Yang ; Libby, Peter ; Matchaba, Patrice ; Ridker, Paul ; Ottewell, Penelope ; Thuren, Tom ; Dugan, Margaret</creatorcontrib><description>Use of an IL-1β binding antibody or a functional fragment thereof, especially canakinumab or a functional fragment thereof, or gevokizumab or a functional fragment thereof, and biomarkers for the treatment and/or prevention of cancer with at least partial inflammatory basis.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210722&DB=EPODOC&CC=AU&NR=2018287519B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210722&DB=EPODOC&CC=AU&NR=2018287519B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Ligueros-Saylan, Monica</creatorcontrib><creatorcontrib>Lau, Yi Yang</creatorcontrib><creatorcontrib>Libby, Peter</creatorcontrib><creatorcontrib>Matchaba, Patrice</creatorcontrib><creatorcontrib>Ridker, Paul</creatorcontrib><creatorcontrib>Ottewell, Penelope</creatorcontrib><creatorcontrib>Thuren, Tom</creatorcontrib><creatorcontrib>Dugan, Margaret</creatorcontrib><title>IL-1beta binding antibodies for use in treating cancer</title><description>Use of an IL-1β binding antibody or a functional fragment thereof, especially canakinumab or a functional fragment thereof, or gevokizumab or a functional fragment thereof, and biomarkers for the treatment and/or prevention of cancer with at least partial inflammatory basis.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDDz9NE1TEotSVRIysxLycxLV0jMK8lMyk_JTC1WSMsvUigtTlXIzFMoKUpNLAFJJyfmJacW8TCwpiXmFKfyQmluBhU31xBnD93Ugvz41OKCxOTUvNSSeMdQIwNDCyMLc1NDSycnI2MilQEAQhYuLg</recordid><startdate>20210722</startdate><enddate>20210722</enddate><creator>Ligueros-Saylan, Monica</creator><creator>Lau, Yi Yang</creator><creator>Libby, Peter</creator><creator>Matchaba, Patrice</creator><creator>Ridker, Paul</creator><creator>Ottewell, Penelope</creator><creator>Thuren, Tom</creator><creator>Dugan, Margaret</creator><scope>EVB</scope></search><sort><creationdate>20210722</creationdate><title>IL-1beta binding antibodies for use in treating cancer</title><author>Ligueros-Saylan, Monica ; Lau, Yi Yang ; Libby, Peter ; Matchaba, Patrice ; Ridker, Paul ; Ottewell, Penelope ; Thuren, Tom ; Dugan, Margaret</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2018287519BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Ligueros-Saylan, Monica</creatorcontrib><creatorcontrib>Lau, Yi Yang</creatorcontrib><creatorcontrib>Libby, Peter</creatorcontrib><creatorcontrib>Matchaba, Patrice</creatorcontrib><creatorcontrib>Ridker, Paul</creatorcontrib><creatorcontrib>Ottewell, Penelope</creatorcontrib><creatorcontrib>Thuren, Tom</creatorcontrib><creatorcontrib>Dugan, Margaret</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Ligueros-Saylan, Monica</au><au>Lau, Yi Yang</au><au>Libby, Peter</au><au>Matchaba, Patrice</au><au>Ridker, Paul</au><au>Ottewell, Penelope</au><au>Thuren, Tom</au><au>Dugan, Margaret</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>IL-1beta binding antibodies for use in treating cancer</title><date>2021-07-22</date><risdate>2021</risdate><abstract>Use of an IL-1β binding antibody or a functional fragment thereof, especially canakinumab or a functional fragment thereof, or gevokizumab or a functional fragment thereof, and biomarkers for the treatment and/or prevention of cancer with at least partial inflammatory basis.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_AU2018287519BB2 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | IL-1beta binding antibodies for use in treating cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T06%3A04%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Ligueros-Saylan,%20Monica&rft.date=2021-07-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2018287519BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |